Outpace Bio
Biotechnology Research • 
Seattle, Washington, United States • 51-100 Employees
Company overview
| Headquarters | 700 Dexter Ave N, Suite 300, Seattle, Washington 98109, US |
| Phone number | +12064221367 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Cell Therapy, Immuno-Oncology, Cytokines, Cell Engineering, Protein Design |
| Founded | 2020 |
| Employees | 51-100 |
| Socials |
Key Contacts at Outpace Bio
Marc Lajoie
Co-Founder, Chief Executive Officer
Michael Covarrubias
Senior Director
Scott Boyken
Co-Founder, Chief Technology Officer
Shujun Yuan
Sr. Director, Synthetic Biology And Biophysics
Lindsie Goss
Senior Director, Business Development
Celine Jacquemont
Executive Director, Head Of Translational Sciences
Howell Moffett
Director, Immunology
Gunnar Nordquist
Director Of Fp&A
Thanh Huyen Carranceja
Owner
Jen Running Deer
Associate Director
Outpace Bio Email Formats
Outpace Bio uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@outpacebio.com), used 92.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@outpacebio.com | 92.7% |
{first initial}{last name} | jdoe@outpacebio.com | 7.3% |
About Outpace Bio
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.
Outpace Bio revenue & valuation
| Annual revenue | $1,000,000 |
| Revenue per employee | $15,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,200,000 |
| Total funding | $169,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Outpace Bio has 22 employees across 11 departments.
Departments
Number of employees
Funding Data
Explore Outpace Bio's funding history, including investment rounds, total capital raised, and key backers.
Outpace Bio Tech Stack
Discover the technologies and tools that power Outpace Bio's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
JavaScript libraries
Webmail
Miscellaneous
Security
Miscellaneous
Page builders
JavaScript libraries
Miscellaneous
CDN
United Kingdom
Canada
Frequently asked questions
4.8
40,000 users
